Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketogenic Diet for Prevention of Epileptic Spasms in Infantile Onset Genetic Epilepsies
NCT06700811Phase 1Terminated
- Start
- Aug 2025
- Primary completion
- Sep 2026
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in epileptic spasms (IS), genetic epilepsy and Developmental and Epileptic Encephalopathies (DEE). Primary endpoints: Achievement of ketosis and EEG compliance. Started Aug 2025; status: terminated.
02
Conditions
epileptic spasms (IS)genetic epilepsyDevelopmental and Epileptic Encephalopathies (DEE)
Beyond the preview
Go deeper on NCT06700811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06700811.